COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $223,000 | -4.7% | 23,204 | -28.3% | 0.01% | -20.0% |
| Q2 2022 | $234,000 | -54.3% | 32,347 | -18.5% | 0.01% | -58.3% |
| Q1 2022 | $512,000 | +84.2% | 39,676 | +128.0% | 0.02% | +41.2% |
| Q4 2021 | $278,000 | -42.2% | 17,404 | -47.2% | 0.02% | -61.4% |
| Q1 2021 | $481,000 | +40.6% | 32,947 | +72.0% | 0.04% | +83.3% |
| Q2 2020 | $342,000 | -38.6% | 19,152 | -24.0% | 0.02% | -52.0% |
| Q2 2019 | $557,000 | +92.1% | 25,213 | +18.7% | 0.05% | +138.1% |
| Q1 2019 | $290,000 | -75.3% | 21,236 | -70.2% | 0.02% | -76.1% |
| Q3 2018 | $1,176,000 | +583.7% | 71,266 | +481.8% | 0.09% | +633.3% |
| Q2 2018 | $172,000 | -55.9% | 12,250 | -65.3% | 0.01% | -55.6% |
| Q1 2018 | $390,000 | +22.3% | 35,252 | +134.1% | 0.03% | -34.1% |
| Q1 2017 | $319,000 | -44.4% | 15,061 | -29.7% | 0.04% | -68.0% |
| Q3 2016 | $574,000 | +69.8% | 21,421 | +6.9% | 0.13% | +190.9% |
| Q2 2016 | $338,000 | -56.0% | 20,039 | -47.8% | 0.04% | -33.3% |
| Q3 2015 | $769,000 | – | 38,400 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |